Literature DB >> 29619877

The estrogen-related receptors in metabolism and cancer: newer insights.

Harmit S Ranhotra1.   

Abstract

The eukaryotic nuclear receptors (NRs) super-family of transcriptional factors include the estrogen-related receptors (ERRs) that have diverse roles in control of cellular energy balance, general metabolism, growth and development, immunity etc. Mouse knock-out models of specific ERR isoforms (ERRα, ERRβ and ERRγ) exhibit defects in several phenotypic traits. Newer findings indicate important roles of ERRs in the regulation of brown adipocyte tissue mitochondrial oxidative functions as well as metabolic control in association with hypoxia-inducible factors during cellular hypoxic state. Genes involved in cardiac metabolism is also influenced by ERRα and ERRγ in association with the co-activators PGC-1α and PGC-1β. On the other hand, ERRs have crucial involvement at the interface of metabolism and diseases such as cancer. Recent findings have implicated ERRα in the progression of tumor and malignancy of the breast, prostate, colon, endometrium etc. In this article, new insights into the regulatory role of ERRs in metabolism and cancer shall be reviewed.

Entities:  

Keywords:  Estrogen-related receptors; cancer; energy balance; metabolism

Mesh:

Substances:

Year:  2018        PMID: 29619877     DOI: 10.1080/10799893.2018.1456552

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

Review 1.  The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy.

Authors:  Shirin A Hafezi; Wael M Abdel-Rahman
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 2.  Estrogen-related receptor alpha in select host functions and cancer: new frontiers.

Authors:  Harmit S Ranhotra
Journal:  Mol Cell Biochem       Date:  2022-02-09       Impact factor: 3.396

3.  The YAP/SERCA2a signaling pathway protects cardiomyocytes against reperfusion-induced apoptosis.

Authors:  Jiankai Zhong; Haichun Ouyang; Sulin Zheng; Zhongzhou Guo; Yuying Chen; Yuanlin Zhong; Wenhao Zhong; Liuer Zuo; Jianhua Lu
Journal:  Aging (Albany NY)       Date:  2020-07-09       Impact factor: 5.682

Review 4.  Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.

Authors:  Edit Mikó; Tünde Kovács; Éva Sebő; Judit Tóth; Tamás Csonka; Gyula Ujlaki; Adrienn Sipos; Judit Szabó; Gábor Méhes; Péter Bai
Journal:  Cells       Date:  2019-03-29       Impact factor: 6.600

5.  Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer.

Authors:  Shi-Lei Liu; Hai-Bin Liang; Zi-Yi Yang; Chen Cai; Zi-You Wu; Xiang-Song Wu; Ping Dong; Mao-Lan Li; Lei Zheng; Wei Gong
Journal:  Int J Med Sci       Date:  2022-01-04       Impact factor: 3.738

6.  miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells.

Authors:  Fei Liu; Chunsheng Gao; Wenjuan Wang; Jing Hu; Zuofeng Huang; Meng Liang; Shuo Li
Journal:  J Cell Commun Signal       Date:  2021-07-01       Impact factor: 5.782

7.  Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction.

Authors:  Ting Xin; Chengzhi Lu
Journal:  Aging (Albany NY)       Date:  2020-03-10       Impact factor: 5.682

Review 8.  Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.

Authors:  Chia-Lin Chen; Ching-Yu Lin; Hsing-Jien Kung
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.